After a 2 week screening period all eligible participants were randomly assigned to treatment groups receiving either a subcutaneous injection of 2.4 mg of semaglutide, 2.4 mg of cagrilintide, a combination of cagrilintide and semaglutide, a semaglutide placebo, or a cagrilintide placebo [2]
The most common retatrutide side effects at the 12mg dose are nausea (28%), diarrhea (24%), constipation (21%), and vomiting (17%)
When looking at the percentage of participants that dropped out of the trial due to adverse effects, 2-6% of patients in the cagrilintide group discontinued treatment early while 7% of the participants receiving liraglutide discontinued treatment early, These findings were in comparison to only 3% of test subjects from the placebo group that discontinued treatment due to adverse events [1]
The Wolverine Stack for Chronic Pain This is where things get especially interesting
How it's used Given by mouth or by injection in animal research If you've searched for dihexa, you've probably seen a number thrown around that it's some enormous multiple more potent than BDNF, a natural brain growth factor
